| Industry | Sector | Country | Exchange |
| Dow | S&P 500 | NASDAQ 100 | Russell 2K |
| your portfolio performance (Comp) | Key Metrics (Comp) | (Comp) |
| Industry: Diagnostic Substances |
| NEOG | Industry | |
| EVS | 9.2 | |
| Avg Volume | 193.1 | |
| 1 Week Perf | +0.23% | |
| 3 Month Perf | +0.42% | |
| 1 Year Perf | +30.65% | |
| %off 50D High | -0.26% | |
| %off 52W High | -8.92% | |
| P/E | 61.09 | |
| Forward P/E | 44.79 | |
| PEG | 3.9 | |
| P/S | 7.16 | |
| P/B | 5.65 | |
| P/Cash | 18.73 | |
| P/FCF | 69.48 | |
| EPS (TTM) | 0.91 | |
| EPS Gr(NextY) | +15.87% | |
| EPS Gr(Past5Y) | +12.00% | |
| EPS Gr(Next5Y) | +15.67% | |
| Rev Gr(Past5Y) | +15.00% | |
| Debt/Equity | 0 | |
| Gross Margin | 49.40% | |
| Oper Margin | 23.50% | |
| Prof Margin | 14.70% | |
| Market Cap | 2077.4 |